Company Filing History:
1 out of 832,812 Years Active: 2021
Title: Cristina Mallol Dominguez: Innovator in Diabetes Treatment
Introduction
Cristina Mallol Dominguez is a prominent inventor based in Cerdanyola del Valles, Spain. She has made significant contributions to the field of biotechnology, particularly in the treatment of diabetes. Her innovative work focuses on the development of viral vectors that can potentially transform diabetes management.
Latest Patents
Cristina holds 1 patent for her groundbreaking invention titled "Viral vectors for the treatment of diabetes." This patent involves gene constructs that comprise a nucleotide sequence encoding the Insulin-like growth factor 1 (IGF-1) of a mammal. The invention also includes target sequences of a microRNA that aims to prevent the expression of IGF-1 in specific tissues. These sequences are operationally linked to a promoter of ubiquitous expression. The expression vectors and pharmaceutical compositions derived from this invention are designed to treat and prevent diabetes mellitus in mammals, particularly in cases where there is dysfunction or loss of beta-cells in the islets of Langerhans.
Career Highlights
Cristina's career is marked by her dedication to advancing medical science through innovative research. Her work has the potential to significantly impact the lives of individuals suffering from diabetes. She is recognized for her expertise and commitment to finding effective solutions for this chronic condition.
Collaborations
Cristina has collaborated with notable colleagues in her field, including Fatima Bosch Tubert and Veronica Jimenez Cenzano. These partnerships have fostered a collaborative environment that enhances the research and development of her innovative solutions.
Conclusion
Cristina Mallol Dominguez is a trailblazer in the field of diabetes treatment, with her innovative patent paving the way for future advancements. Her contributions to biotechnology exemplify the impact of dedicated research on improving health outcomes.